Bilirubin Inhibits NLRP3 Inflammasome Activation by Maintaining the Stability of Mitochondria Membranes

Yufei Li,Hongda Sheng,Jing Qian,Yi Wang

DOI: https://doi.org/10.2139/ssrn.3936379

2021-01-01

Abstract:The NLRP3 inflammasome, a protein complex that activates the secretion of the proinflammatory cytokines including IL-1β plays vital roles in innate immune responses during infection or incurable inflammatory diseases. It is now become clear that mitochondria senses both intracellular and extracellular stress and that the subsequence released mt-ROS being direct triggers for NLRP3 inflammasome activation. Bilirubin is a byproduct of heme metabolism that possess antioxidant and immunosuppressive effects at physiologic or moderately elevated levels. We have previously reported that physiological concentrations of bilirubin inhibit inflammation through inhibiting both the NF-κB signaling and inflammasome activation. In current study, we investigated the role and mechanism of bilirubin in controlling the NLRP3 inflammasome activation. The experiments were designed by adding of bilirubin shortly (30 min) before the ATP stimulation. In addition to detect the releasing of IL-1β and TNF-α by ELSIA, the forming of ASC oligomerization and ASC-speck formation as well as pro-caspase-1 recruitment were assessed by immunofluorescences staining or co-immunoprecipitation followed by western blotting. Meanwhile, emphases were addressed on evaluating the effects of bilirubin on mitochondria. In addition to detect the its antioxidant bioactivity by biochemical and living cell fluoresce staining assays for NO and mtROS, multiplexed high-content mitochondria imaging analysis was applied to evaluate mitochondrial morphofunction. We confirmed that physiological concentrations of bilirubin inhibit NLRP3 inflammasome activation associated with the stabilization of mitochondria morphofunction, the mechanism of which is likely related to its antioxidant bioactivity. Our results support the potential of defined doses of bilirubin as medication against inflammasome related diseases.